ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancers and describes a type of breast cancer whose cells do not overexpress the human epidermal growth factor receptor 2 (HER2) or receptors for estrogen and progesterone [2].